Page last updated: 2024-08-25
nedaplatin and ampelopsin
nedaplatin has been researched along with ampelopsin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jiang, L; Li, M; Liang, J; Liu, B; Liu, J; Lu, C; Ma, S; Ren, H; Zhang, Q; Zhu, R | 1 |
Other Studies
1 other study(ies) available for nedaplatin and ampelopsin
| Article | Year |
|---|---|
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Flavonols; Humans; Liver Neoplasms; Organoplatinum Compounds; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2015 |